Stephen Industries

StemSight is a cell therapy startup based in Tampere, Finland, focused on developing innovative treatments for blindness. The company is creating an off-the-shelf cell therapy platform that utilizes induced pluripotent stem cells (iPSCs) and biomaterials. Its initial product aims to address limbal stem cell deficiency, a rare condition that affects vision. StemSight plans to expand its offerings to include therapies for more common forms of corneal blindness, with the ultimate goal of helping patients regain their sight.

Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

Hycamite TCD Technologies is a privately-owned company focused on commercializing innovative environmental technology developed through collaborations with various European universities. The company's primary objective is to produce clean hydrogen by processing methane while eliminating carbon dioxide emissions. Hycamite's technology effectively separates methane into hydrogen and solid, high-quality carbon, creating both clean hydrogen and pure carbon. This process allows businesses to decompose methane from natural gas or biogas into its elemental components, offering valuable industrial raw materials and fuel.

Fiberwood is a manufacturer of eco-friendly wood fiber insulation and packaging materials aimed at promoting sustainable construction and packaging solutions. The company utilizes foam-forming technology to produce thermal insulation boards from forestry by-products and other natural fibers, ensuring that its products are entirely bio-based and free from plastic and fossil materials. Fiberwood's offerings provide excellent insulating properties and serve as recyclable, resource-efficient alternatives to traditional mineral wool insulation and cellular plastic packaging. By focusing on sustainability, Fiberwood enables clients to adopt environmentally responsible methods for insulation and packaging, contributing to a greener construction industry.

NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient recovery. NPHarvest is a research project aiming to enable efficient and profitable nitrogen recycling from waste flows to the fertilizer market, utilizing energy-efficient hydrophobic membrane stripping and ballasted sedimentation of phosphorus with lime.

Ninyes operates a resale-as-a-service platform aimed at enhancing profitability for sustainable fashion brands in the growing secondhand market. By transforming the traditional peer-to-peer resale model into a professional business-to-business service, Ninyes offers a comprehensive solution that includes logistics, warehousing, selling, and marketing of second-hand clothing and accessories. Additionally, the company provides data and analytics to optimize the resale process, allowing fashion brands to leverage multiple market and sales channels effectively. Through its innovative approach, Ninyes enables brands to benefit from the expanding resale market while promoting sustainability in fashion.

Hycamite TCD Technologies is a privately-owned company focused on commercializing innovative environmental technology developed through collaborations with various European universities. The company's primary objective is to produce clean hydrogen by processing methane while eliminating carbon dioxide emissions. Hycamite's technology effectively separates methane into hydrogen and solid, high-quality carbon, creating both clean hydrogen and pure carbon. This process allows businesses to decompose methane from natural gas or biogas into its elemental components, offering valuable industrial raw materials and fuel.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.

Fiberwood is a manufacturer of eco-friendly wood fiber insulation and packaging materials aimed at promoting sustainable construction and packaging solutions. The company utilizes foam-forming technology to produce thermal insulation boards from forestry by-products and other natural fibers, ensuring that its products are entirely bio-based and free from plastic and fossil materials. Fiberwood's offerings provide excellent insulating properties and serve as recyclable, resource-efficient alternatives to traditional mineral wool insulation and cellular plastic packaging. By focusing on sustainability, Fiberwood enables clients to adopt environmentally responsible methods for insulation and packaging, contributing to a greener construction industry.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.